[go: up one dir, main page]

SV2006002355A - Formulaciones inyectables o administrables por via oral de derivados de azetidina - Google Patents

Formulaciones inyectables o administrables por via oral de derivados de azetidina

Info

Publication number
SV2006002355A
SV2006002355A SV2005002355A SV2005002355A SV2006002355A SV 2006002355 A SV2006002355 A SV 2006002355A SV 2005002355 A SV2005002355 A SV 2005002355A SV 2005002355 A SV2005002355 A SV 2005002355A SV 2006002355 A SV2006002355 A SV 2006002355A
Authority
SV
El Salvador
Prior art keywords
derivatives
injectable
oral route
azetidina
administrable formulations
Prior art date
Application number
SV2005002355A
Other languages
English (en)
Inventor
Maria Teresa Peracchia
Gilbert Gaudel
Sophie Cote
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SV2006002355A publication Critical patent/SV2006002355A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A FORMULACIONES BINARIAS O TERNARIAS INYECTABLES O ADMINISTRABLES POR VÍA ORAL DE DERIVADOS DE AZETIDINA.LOS DERIVADOS DE AZETIDINA UTILIZADOS EN LAS COMPOSICIONES FARMACÉUTICAS SEGÚN LA INVENCIÓN PUEDEN DESIGNARSE POR LA FORMULAS GENERALES (IA) O (IB) A CONTINUACIÓN: (VER FORMULA) EN LAS QUE AR ES UN GRUPO AROMÁTICO O HETEROAROMÁTICO OPCIONALMENTE SUSTITUIDO POR UNO O VARIOS ALQUILO (C1-C4), HALÓGENO, NO2, CN, ALCOXI (C1-C4) Y OH
SV2005002355A 2004-12-27 2005-12-22 Formulaciones inyectables o administrables por via oral de derivados de azetidina SV2006002355A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0413937A FR2879932B1 (fr) 2004-12-27 2004-12-27 Formulations injectable ou administrable par voie orale de derives d'azetidine

Publications (1)

Publication Number Publication Date
SV2006002355A true SV2006002355A (es) 2006-06-28

Family

ID=34952941

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002355A SV2006002355A (es) 2004-12-27 2005-12-22 Formulaciones inyectables o administrables por via oral de derivados de azetidina

Country Status (20)

Country Link
US (2) US20070244085A1 (es)
EP (1) EP1835906A1 (es)
JP (1) JP2008525390A (es)
KR (1) KR20070092970A (es)
CN (1) CN101090719A (es)
AR (1) AR052181A1 (es)
AU (1) AU2005321112A1 (es)
BR (1) BRPI0519271A2 (es)
CA (1) CA2586895A1 (es)
FR (1) FR2879932B1 (es)
GT (1) GT200500387A (es)
IL (1) IL183483A0 (es)
MX (1) MX2007006926A (es)
PA (1) PA8658201A1 (es)
PE (1) PE20060743A1 (es)
RU (1) RU2007128812A (es)
SV (1) SV2006002355A (es)
TW (1) TW200635581A (es)
UY (1) UY29318A1 (es)
WO (1) WO2006070129A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110056516A (ko) * 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 점막 또는 피부를 통한 치료제의 흡수 개선
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
AU2016245984B2 (en) 2015-04-10 2021-03-25 Bioresponse, L.L.C. Self-emulsifying formulations of DIM-related indoles
EP3986856A4 (en) 2019-06-18 2023-07-19 Opiant Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF CANNABINOID HYPEREMESSI SYNDROME WITH A CANNABINOID RECEPTOR ANTAGONIST

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0177158B1 (ko) * 1990-03-01 1999-03-20 후지사와 도모기찌로 면역억제 활성을 갖는 트리사이클릭 화합물 함유 용액 제제
US5516770A (en) * 1993-09-30 1996-05-14 American Home Products Corporation Rapamycin formulation for IV injection
EP1185301A1 (en) * 1999-05-24 2002-03-13 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
CA2586895A1 (fr) 2006-07-06
US20100022501A1 (en) 2010-01-28
UY29318A1 (es) 2006-07-31
CN101090719A (zh) 2007-12-19
MX2007006926A (es) 2007-08-06
US20070244085A1 (en) 2007-10-18
BRPI0519271A2 (pt) 2009-01-06
TW200635581A (en) 2006-10-16
PA8658201A1 (es) 2006-08-03
IL183483A0 (en) 2007-09-20
WO2006070129A1 (fr) 2006-07-06
FR2879932A1 (fr) 2006-06-30
PE20060743A1 (es) 2006-09-13
GT200500387A (es) 2006-07-03
AR052181A1 (es) 2007-03-07
JP2008525390A (ja) 2008-07-17
FR2879932B1 (fr) 2007-03-23
EP1835906A1 (fr) 2007-09-26
AU2005321112A1 (en) 2006-07-06
RU2007128812A (ru) 2009-02-10
KR20070092970A (ko) 2007-09-14

Similar Documents

Publication Publication Date Title
AR043049A1 (es) Derivados de hidantoina, proceso de preparacion del mismo y composicion farmaceutica
AR062109A1 (es) Derivados sustituidos de espirocetal y uso de los mismos como farmacos terapeuticos para la diabetes. composiciones farmaceuticas.
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
ECSP067076A (es) Derivados de pirimidina urea como inhibidores de la quinasa
ECSP099335A (es) Compuestos heterocíclicos que contienen nitrógeno y métodos de uso de los mismos
EA200870423A1 (ru) Производные триазолпиразинов, применимые в качестве противораковых агентов
ECSP088549A (es) Nuevos derivados de pirrol fusionado
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
DK1934174T3 (da) Azetidiner som MEK inhibitorer til behandling af proliferative sygdomme
CR9602A (es) Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
AR088808A2 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
NO20075111L (no) Farmasoytisk sammensetning
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
UY31457A1 (es) Derivados acidos de cicloalquilamino
ATE368666T1 (de) Pyrazolopyrimidinone und ihre verwendung als pde inhibitoren
SV2009003348A (es) Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen
EA200800546A1 (ru) Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk)
MX2009003169A (es) Derivados de sulfonamida.
ECSP088257A (es) Derivados de amida
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
UY29510A1 (es) Derivados de urea, metodos para su fabricación, y usos de los mismos
SV2006002355A (es) Formulaciones inyectables o administrables por via oral de derivados de azetidina